Orthofix Medical

Traded on the St. Petersburg Stock Exchange
Orthofix Medical Inc. a medical device and biologics company in the United States, Italy, Germany, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Extremities.
Orthofix Medical stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Orthofix Medical balance sheet

Report period2018 2019 2020 2021 2022 Q1 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Orthofix Medical cash flows

Report period2018 2019 2020 2021 2022 Q1 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Orthofix Medical multipliers

Report period2018 2019 2020 2021 2022 Q1 23 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

Orthofix Medical profitability

Report period2018 2019 2020 2021 2022 Q1 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Orthofix Medical assets
Orthofix Medical cash flows

Orthofix Medical shares

TickerNameTypeNominal valueISINPrice
OFIX:USOrthofix Medical, Inc.Common share-US68752M1080$13.43
Orthofix Medical news
06.05.2022
Orthofix Medical's GAAP loss for 3 months of 2022 was $4.46 million, down 23.3% from $5.816 million in the prior year. Revenue increased 0.8% to $106.418 million from $105.593 million a year earlier.
25.02.2022
Orthofix Medical's GAAP loss for 2021 was $38.379 million, compared to a profit of $2.517 million in the previous year. Revenue increased 14.2% to $464.479 million from $406.562 million a year earlier.
05.11.2021
Orthofix Medical reported a GAAP loss of $5.567 million for 9M 2021, against a profit of $11.895 million in the previous year. Revenue increased 17.5% to $339.415 million from $288.943 million a year earlier.
06.08.2021
Orthofix Medical' GAAP loss for six months 2021 was $3.396 million, compared to a profit of $7.241 million in the previous year. Revenue increased 27.6% to $226.987 million from $177.958 million a year earlier.
General information
Company nameOrthofix Medical
Tags#medtech
SectorHealth Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Equipment
Business address3451 PLANO PARKWAY LEWISVILLE TX 75056 214-937-2000
Mailing address3451 PLANO PARKWAY LEWISVILLE TX 75056
Websitewww.orthofix.com
Information disclosurewww.sec.gov